Opyl Ltd. (AU:OPL) has released an update.
Opyl Limited has announced the issuance of over 21.5 million fully paid ordinary shares, marking a significant move in its strategic growth plan within the AI-powered healthcare sector. The company is committed to leveraging technology to transform clinical trials and medical research, positioning itself as a leader in future healthcare solutions.
For further insights into AU:OPL stock, check out TipRanks’ Stock Analysis page.